– ISRAEL, Tel Aviv – Radiaction Medical, LTD, a medical device company whose mission is to provide radiation protection to the entire medical staff during interventional procedures, today announced the election of Christopher Barys to its Board of Directors, bringing 30+ years of medical device sales, marketing, and business experience, including leading growth and innovation within the cardiac catheterization and image-guided spaces.
The company also announced having raised $12.6 million in Series C2 funding led by InnovaHealth Partners.
Christopher Barys said, “I am thrilled to be a part of Radiaction’s mission to provide advanced radiation protection to the entire procedural staff. Now more than ever, the medical community needs innovative solutions to pressing systemic problems. Radiaction is disrupting the industry for the better. I am looking forward to supporting Radiaction in bringing its radiation reduction solution to every catheterization lab in the U.S. and abroad.”
About Radiaction
Radiaction Medical, Ltd., is revolutionizing radiation protection for interventional medical teams, focused on specialties that endure the highest exposure rates and serious health risks. In a complete departure from current solutions that shield or clothe users to block radiation, the company created Radiaction, a plug-and-play addition to C-arm systems that dynamically and proactively blocks up to 97% of scatter radiation at the source, offering head-to-toe protection for everyone in the room. Radiaction has received CE Marking and FDA clearance and is currently being marketed in North America.
Based in Tel Aviv, Israel, Radiaction Medical was founded by Amir Belson, MD, with lead investor InnovaHealth Partners, LP. Engineering excellence allows the company to surmount real-world challenges and limitations and make a lasting impact.
Radiaction is rapidly expanding its footprint in the United States, adding new sites to its user base, providing key support staff to ensure the success of each system installation, developing additional features, and growing its clinical publication pipeline to support the technology’s performance with clinical data.
For more information: https://radiactionmedical.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
